Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks

Trial Profile

Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 17 Aug 2016

At a glance

  • Drugs Mifepristone (Primary) ; Misoprostol
  • Indications Abortion
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Aug 2016 Status changed from not yet recruiting to active, no longer recruiting.
    • 17 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top